Navigation Links
Stroke Study Reveals a Key Target For Improving Treatment
Date:6/22/2008

Research in mice shows why tPA carries risks as well as benefits, and suggests that Gleevec or other drugs could prevent problems

ANN ARBOR, Mich., June 22 /PRNewswire-USNewswire/ -- For over a decade, the drug called tPA has proven its worth as the most effective emergency treatment for the most common kind of stroke. But its promise is blemished by two facts: tPA can cause dangerous bleeding in the brain, and its brain-saving power fades fast after the third hour of a stroke.

Now, a new paper published online in Nature Medicine reveals why tPA has these limitations. It also gives tantalizing evidence about how those problems might be overcome, if a stroke victim first takes a drug currently used to treat leukemia.

The researchers, from the University of Michigan and the Ludwig Institute for Cancer Research (LICR) Stockholm Branch at Karolinska Institutet in Stockholm, Sweden, emphasize that it's still too early to apply their findings -- made in mice -- to the treatment of stroke victims everywhere.

But the LICR-Karolinska Institutet team will soon begin a clinical trial to test the theory in humans, using the leukemia drug known as imatinib (Gleevec). In mice, that drug greatly reduced bleeding, even if tPA wasn't given until five hours after a stroke began.

The new paper details a series of molecular and cellular experiments conducted by the two teams, which began collaborating after hearing of each other's work.

They report that tPA apparently causes its risk of bleeding, and leakage of fluid within the brain, by accident. The culprit: tPA's tendency to act upon a protein called PDGF-CC, and the PDGF-alpha receptor that it binds to. This interaction causes the usually impervious "blood-brain barrier" to become porous, leading to leakage. Gleevec inhibits the PDGF-alpha receptor, apparently counteracting tPA's effect.

This unwanted effect on the blood-brain barrier appears to be unrelated to tPA's main job,
'/>"/>

SOURCE University of Michigan Health System
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cleveland Clinic Study Shows the Diabetes Drug Pioglitazone Reduces Risk of Death, Heart Attack and Stroke, but Increases Risk of Heart Failure
2. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
3. Nuvelo Begins Phase 2 Trial and Receives Fast Track Status for Alfimeprase in Patients With Acute Ischemic Stroke
4. FASgen Announces New Discovery for Treatment of Stroke
5. ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
6. Fifth DSMB Meeting Supports Neurobiological Technologies Continuation of Phase 3 Stroke Trials With Viprinex(TM) (ancrod)
7. Neurobiological Technologies, Inc. Presents Dosing Rationale for Viprinex(TM) (ancrod) at the European Stroke Conference
8. PRoFESS(R) Results Announced at XVII European Stroke Conference
9. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
10. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
11. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... Statistics released from a number of organizations ... during the holidays, beginning with Thanksgiving eve, which is ... The data, highlighted in an Infographic ... of their annual Sober Days for the Holidays ... drinking and increased rates of DUI injuries and deaths ...
(Date:11/22/2014)... 2014 Many power shifts are occurring ... of patients in the biopharmaceutical market is impacting ... than ever, understanding how to effectively acquire, convert, ... essential. According to recent research ... spent about two-thirds of their patient-focused dollars on ...
(Date:11/21/2014)... DIEGO , Nov. 21, 2014  Tandem ... TNDM ), a medical device company and manufacturer ... announced a partnership with Tidepool, a non-profit dedicated ... open source software platform that increases diabetes data ... Tidepool Platform, which is currently under development, to ...
Breaking Medicine Technology:Alarming Stats Show Holiday Drinking an Issue for Many 2New Report Details Importance of Adopting a "Patient Journey" Framework in Marketing 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 2Tandem Diabetes Care Announces Partnership with Tidepool to Further Expand Access to Diabetes Device Data 3
... Cantel Medical Corp. (NYSE: CMN ) will release the ... Tuesday, June 8 before the market opens, and hold a conference call ... call will be Charles M. Diker , Chairman; Andrew A. Krakauer ... Craig A. Sheldon , Senior Vice President, CFO and Treasurer; and Roy ...
... Fla. , June 1 In a ... records management, MedeFile International, Inc. (OTC Bulletin Board: MDFI.OB), ... announced the signing of an unprecedented agreement with Dr. ... and Registered Nurse in the practice will be incorporating ...
Cached Medicine Technology:Cantel Medical Corp. to Hold Conference Call to Discuss Results for Its Third Quarter Ended April 30, 2010 2In First of Its Kind Setup, MedeFile Interfacing Directly with Physician's Office 2In First of Its Kind Setup, MedeFile Interfacing Directly with Physician's Office 3In First of Its Kind Setup, MedeFile Interfacing Directly with Physician's Office 4
(Date:11/24/2014)... 2014 The typical American diet includes ... ingredients. Consistently consuming a diet high in calories and ... excess fat that typically accumulate around the internal organs ... ugly head in the form of love handles, beer ... the decision to rid themselves of the burden of ...
(Date:11/24/2014)... CO, and Philadelphia, PA (PRWEB) November 24, 2014 ... provider of care coordination and disease management services ... has chosen to implement Essette’s Medical Management software ... new Essette SaaS platform in a program to ... Essette suite includes Population Health Management, Care Management, ...
(Date:11/24/2014)... San Diego, California (PRWEB) November 24, 2014 ... the San Diego Fertility Center, recently appeared on NBC to ... preservation option. Egg freezing has been trending in the news ... covering this expensive procedure for women. , “[The ... the women who are on a career hot path.” Says ...
(Date:11/23/2014)... The clinical trial report, "Aspergillosis ... on the Aspergillosis clinical trial scenario. This report ... clinical trials on Aspergillosis. It includes an overview ... as per the site of trial conduction across ... of disease clinical trials by their phase, trial ...
(Date:11/23/2014)... For the coming special Friday, Tidebuy, a ... great promotion for many products, especially the beautiful colored ... best choice with amazing discounts, up to 90% off. ... It is easy to buy colored wedding dresses in ... is also famous for delicate craftsmanship, elegant style and ...
Breaking Medicine News(10 mins):Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 2Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 3Health News:Ketogenic Diet is the Perfect Solution for Diet Doc Patients Who Want to Learn How to Lose Weight over the Holidays 4Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 2Health News:Dr. Michael Kettel of San Diego Fertility Center Gives “An Inside Look at Freezing Eggs” on NBC 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 2Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 3Health News:Aspergillosis Pipeline and Clinical Trials Market (Compnies and Drugs) Review H2 2014 Report at ReportsnReports.com 4Health News:Beautiful Wedding Dresses Available at Popular B2C Company Tidebuy 2
... national patient safety initiative involving major corporate employers ... goals, but success relies greatly on regional health ... implementation, says a recent study., "While employers and ... safety, actual success depends greatly on individual hospitals ...
... who think they are too fat is worse than ... result of the all Germany Health Interview and Examination ... Koch Institute, as presented by Brbel-Maria Kurth and Ute ... International (Dtsch Arztebl Int 2008, 105[23]: 406-12). , ...
... if children with a urinary tract disorder known as ... for an extended period of time are seeking to ... Intervention for Children with Vesicoureteral Reflux (RIVUR) study is ... and Kidney Diseases (NIDDK), one of the National Institutes ...
... release is available in Spanish . , A ... concluded that there are opioid and cannabinoid receptors ... spermatozoid. The research by Mr Ekaitz Agirregoitia opens the door ... Freshly released spermatozoids cannot achieve fertilisation, they must undergo some ...
... Co-Founder and Attorney Christopher, Grell receives 40 page, 10 year study on ... 99% of distributors earn income, not counting ... expenses, of 13 dollars per week., OAKLAND, Calif., June 20 ... with a presence in over 30 countries,both Usana and Herbalife (NYSE: ...
... and physical exercise can improve coordination and movement ... development disorder that primarily affects females. , Using ... the Children,s Medical Research Institute in Sydney, researchers ... these mice responded positively to the effects of ...
Cached Medicine News:Health News:Changes in local health care markets affect national patient safety project 2Health News:Changes in local health care markets affect national patient safety project 3Health News:Changes in local health care markets affect national patient safety project 4Health News:'Feeling fat' is worse than being it 2Health News:Researchers seek children for a study of antibiotics for a urinary tract disorder 2Health News:Opioids and cannabinoids influence mobility of spermatozoids 2Health News:Opioids and cannabinoids influence mobility of spermatozoids 3Health News:New Lab Tests Reveal Herbalife, Usana Have 1,000 Times the Lead as Ensure, Boost 2Health News:New Lab Tests Reveal Herbalife, Usana Have 1,000 Times the Lead as Ensure, Boost 3Health News:Mental and physical exercise improves genetic mental impairment 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: